Compounds are provided which have the structure 1
wherein Q is C or N; R.sup.2a, R.sup.2b, R.sup.2c, X.sub.1 to X.sub.7,
R.sup.1, R.sup.2, R.sup.3, R.sup.3a, R.sup.4, A, Y, m, and n are as
defined herein, which compounds are useful as antidiabetic,
hypolipidemic, and antiobesity agents. The present invention further
provides a method for treating obesity and dyslipidemia in mammals
including humans through simultaneous inhibition of peroxisome
proliferator activated receptor-.gamma. (PPAR.gamma.) and stimulation of
peroxisome proliferator activated receptor-.alpha. (PPAR.alpha.).